Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma

NCT00001270 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

85

Enrollment

NIH

Sponsor class

Conditions

Breast Neoplasms
Lymphoma
Neoplasm Metastasis
Testicular Neoplasms

Interventions

DRUG: interleukin-1

Sponsor

National Cancer Institute (NCI)